中文         Site Map |
 
 
 
MMV visit Guilin Pharmaceutical Co., Ltd.
Date: Mar.7.2011
 

In March 1st, MMV visited Guilin Pharmaceutical Co., Ltd., the Mayer of Guilin city and the Director of FDA both attend. MMV (MALARIAL MEDICINE VENTURE), working as a NGO specialized in the R&D of anti-malaria medicines, donates keep people out of malaria. There’re 300 million – 500 million patients all over the world, 10% of which is severe malaria and 10% of the severe malaria is child. Any delay for emergency rescue might cause death.

MMV highly praises GUILIN for its PQ product Artesunate for injection. WHO recommend Artesunate for injection as the best choice medicine due to its affectivity and safety showed in AQUMATE. If Artesunate for injection is widely adopted, millions of children’s lives could be saved. Artesunate for injection is the medicine that could save people’s lives for severe patients.

During the interview with MMV, the Mayor of Guilin, Mr. WU is pride of PQ Artesunate for injection of Guilin Pharmaceutical, and said that as one of the long-term strategy, GUILIN will always cooperate with WHO, MMV and other international NGOs. Mr. WU also believed that under the support and help from all sides, GUILIN will complete the political and diplomatic mission honored by the government, using our ACTs resource to make our contributions around the world.

To reply the questions from MMV about the drug administration, the Director of Guilin FDA, Mr. Long, said that as department of Chinese Food and Drug Administration, Guilin FDA will keep on supporting Guilin Pharmaceutical to ensure the safety of the drugs by regulatory activities. Meanwhile, Mr. Long also hope that GUILIN could strengthen R&D, especially the research on new dosage or formulation drugs, to provide high quality medicines in a reasonable price, and to improve the control capacity in all the malaria countries.

The president of Guilin Pharmaceutical, Mr. Yu Zhemin, thanked MMV for their help and supports in all sides, especially technology. GUILIN is the world leading anti-malaria manufacturer, and is fully capable to provide efficient, good quality and affordable products to make great contributions to malaria countries. GUILIN will continually provide the most sincere and selfless assistance for the eradication of malaria all over the world.

MMV conferree: Jorg J. Mohrle, (Director Clinical Development)
                         Timothy N C wells (Chief Scientific Officer)

 

This site is published by Guilin Pharmaceutical (Shanghai) Corporation,        which is solely responsible for its content. All rights reserved.

© Guilin Pharmaceutical (Shanghai) Co., Ltd. 2017.